Shuttle Pharmaceuticals Holdings, Inc. filed a Form D with the Securities and Exchange Commission on 2025-06-26.
Shuttle Pharmaceuticals Holdings, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 26, 2025. Shuttle Pharmaceuticals Holdings, Inc. trades on Nasdaq as SHPH. The filing reports $4.25M sold. Its industry group is Pharmaceuticals. It names Christopher Cooper (Chief Executive Officer), Peter Dritschilo (President and Chief Operating Officer), Mira Jung (Chief Scientific Officer for Biology) (SEC Form D, June 26, 2025).
Is this your company?
Run the free check on Shuttle Pharmaceuticals Holdings, Inc. →
Sell to companies like Shuttle Pharmaceuticals Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-26 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Shuttle Pharmaceuticals Holdings, Inc.
Free to see. No signup.
More on the people and the money behind Shuttle Pharmaceuticals Holdings, Inc., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when Shuttle Pharmaceuticals Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Shuttle Pharmaceuticals Holdings, Inc. raises, hires or launches. No email unless you switch it on.
Watch Shuttle Pharmaceuticals Holdings, Inc. →Get the full cited report on Shuttle Pharmaceuticals Holdings, Inc.
What the filing shows about Shuttle Pharmaceuticals Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Shuttle Pharmaceuticals Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Shuttle Pharmaceuticals Holdings, Inc.'s address as 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Shuttle Pharmaceuticals Holdings, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Shuttle Pharmaceuticals Holdings, Inc. See pricing
Shuttle Pharmaceuticals Holdings, Inc. is a registered filer with the SEC (CIK 1757499) and has filed since 2023-01-20. 5 filings are on record, the latest on 2026-05-15.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Shuttle Pharmaceuticals Holdings, Inc.'s Form D of 2025-06-26 names Christopher Cooper, Peter Dritschilo, Mira Jung and 6 more as its officers, directors or promoters.
Its new offerings report $21.49M sold across 5 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
On the filing as: Executive Officer.
Christopher Cooper is named as Chief Executive Officer on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Peter Dritschilo is named as President and Chief Operating Officer on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Mira Jung is named as Chief Scientific Officer for Biology on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Tyvin Rich is named as Chief Medical Officer on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
On the filing as: Executive Officer.
Timothy Lorber is named as Chief Financial Officer on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
George Scorcis is named as Director on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
Steven Richards is named as Director on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
Oleh Nabyt is named as Director on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
Joseph Tung is named as Director on the Form D that Shuttle Pharmaceuticals Holdings, Inc. filed with the SEC on 26 June 2025, one of 9 people that filing names.
9 people named on the filing — 5 holding an executive role and 4 as directors only.
Named as of the 2025-06-26 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Shuttle Pharmaceuticals Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Shuttle Pharmaceuticals Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Shuttle Pharmaceuticals Holdings, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Shuttle Pharmaceuticals Holdings, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Shuttle Pharmaceuticals Holdings, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Shuttle Pharmaceuticals Holdings, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in Washington, DC
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/shuttle-pharmaceuticals-holdings-inc-form-d-25000002